(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the sorted by
relevance

Admin17.09.2021

(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the

3502
Admin07.10.2021

(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the

Admin23.08.2021

(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the

9403
Admin08.09.2021

Pacritinib (SB1518) | JAK2/FLT3 inhibitor | Buy Pacritinib

8010
Admin02.09.2021

APExBIO - Pacritinib (SB1518)|JAK2/FLT3 inhibitor|CAS

2500
Admin05.08.2021

Pacritinib (SB1518) | CAS:937272-79-2 | JAK2/FLT3

5808
Admin05.09.2021

(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the

1709
Admin08.10.2021

(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the

2209
Admin26.07.2021

Pacritinib (SB1518) | ≥99%(HPLC) | Selleck | JAK inhibitor

2300
Admin14.08.2021

(PDF) The oral HDAC inhibitor pracinostat (SB939) is

904
Admin23.09.2021

(PDF) SB1518, a novel macrocyclic pyrimidine-based JAK2

8600
Admin16.08.2021

SB1518 (Pacritinib) | CAS# 937272-79-2 | 2450 | BioVision

5709
Admin24.09.2021

(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the

2309
Admin13.07.2021

The oral HDAC inhibitor pracinostat (SB939) is efficacious

Admin09.09.2021

(PDF) Phase 1/2 study of pacritinib, a next generation

Admin14.07.2021

Pacritinib inhibits proliferation of AML cells with

5402
Admin11.09.2021

(PDF) Results of a Phase 2 study of pacritinib (SB1518), a

71010
Admin10.09.2021

(PDF) Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the

9903
Admin20.09.2021

Pacritinib (SB1518) | ≥99%(HPLC) | JAK2/FLT3 inhibitor

6504
Admin03.08.2021

Pacritinib (SB1518) | ≥99%(HPLC) | Selleck | JAK inhibitor

46010
Admin29.09.2021

(PDF) The oral HDAC inhibitor pracinostat (SB939) is

4704